Yahoo

Australian Stock Market Today: ASX Futures Edge Up On Inflation Gauge And RBA Decision

The Morning Bull - Australian Market Morning Update Monday, 2 Nov 2026

Australian shares are set for a slightly positive open, with SPI 200 futures pointing to a cautious bid rather than a surge. The focus is squarely on inflation data ahead of tomorrow's RBA decision.

The Melbourne Institute's monthly inflation gauge rose 0.5% in October, with annual inflation sitting at 4.3% in September. Those readings keep alive market expectations that the RBA could lift the cash rate from 4.6% later this year.

Higher rate expectations tend to flow directly into borrowing costs for households and businesses. That can pressure discretionary spending and squeeze profit margins, even as a firm commodity backdrop and a 12.5% yearly rise in the commodity price index support export incomes.

The live question for investors is simple: does the RBA prioritise still elevated inflation, or does it lean into softer indicators like a 5.3% fall in private house approvals when it sets the cash rate tomorrow?

Stocks to Watch Before the Opening Bell

Dicker Data (DDR)

Dicker Data has closed the purchase of 100% of Sektor Group, funded through an extension of existing debt facilities. Sektor produced NZ$440 million in revenue and NZ$22.7 million in normalised EBITDA over the past year. Management is targeting NZ$28 million to NZ$32 million of annualised EBITDA, with the deal widening exposure to point of sale, enterprise mobility and Southeast Asia.

Iluka Resources (ILU)

Iluka Resources has updated the market on its Eneabba rare earth refinery, now 65% built with A$1,237 million of an expected A$1.7 billion to A$1.8 billion spent. The facility is designed to process 55,000 tonnes of concentrate into 23,000 tonnes of rare earth oxides annually. An initial offtake to a global auto group, worth at least US$155 million over four years, is already in place.

oOh!media (OML)

oOh!media shareholders have met to vote on a proposed scheme that would see I Squared Capital acquire the group for $1.68 cash per share. That offer sits inside an independent valuation range of $1.59 to $1.78. The proposal includes scope for a fully franked $0.10 permitted dividend, with final court and FIRB sign offs still required before any payout timetable proceeds.

Top Movers

  • 4DMedical (ASX:4DX)jumped 6.56% after investors reacted to AGM outcomes and the rejected constitutional amendment.

  • Reece (ASX:REH)gained 5.97% as traders weighed AGM commentary and recent full year and Q1 FY27 figures.

  • Bannerman Energy (ASX:BMN)climbed 5.34% following detailed quarterly funding progress and a fresh broker coverage initiation.

ASX:4DX 1-Year Stock Price Chart
ASX:4DX 1-Year Stock Price Chart

Top Losers

  • Turaco Gold (ASX:TCG)declined 9.80% after investors reacted to its A$120 million follow-on equity offering announcement.

  • Helia Group (ASX:HLI)declined 7.93%.

  • Catalyst Metals (ASX:CYL)declined 7.40% amid sector-wide Materials weakness and heavier trading volumes compared with usual activity.

ASX:TCG 1-Year Stock Price Chart
ASX:TCG 1-Year Stock Price Chart

On The Radar

For Australian investors, the next few sessions hinge on the RBA decision and a cluster of heavyweight bank and resource updates that intersect directly with rates, housing and export demand.

  • RBA Interest Rate DecisionTue 3 Nov. Markets are centred on a move from 4.6% to 4.85%. Anything above that would tighten borrowing conditions further for mortgages and small business, while a hold would ease pressure on rate sensitive stocks.

  • RBA Monetary Policy Statement and Press ConferenceTue 3 Nov. The wording around still elevated 4.3% annual inflation and the softer 5.3% fall in private house approvals will shape expectations for how long higher funding costs persist for banks and developers.

  • National Australia BankThu 5 Nov. Full year 2026 results put net interest margins and bad debt charges under the microscope as borrowers adjust to a 4.6% cash rate and talk of further tightening.

  • REA GroupThu 5 Nov. Q1 2027 numbers will show how listing volumes and depth revenues are tracking against weak private house approvals and the recent 5.1% rise in building permits, a key read for housing related advertising.

  • Macquarie GroupFri 6 Nov. First half 2027 earnings will focus on fee income and trading related revenue, which are closely tied to global commodity activity and deal flow that matter for Australian resource and infrastructure exposure.

Sector & Industry Watch

Real Estate: Rate decision looms over REIT rebound

Real Estate has put together a strong 7 day and 30 day run, even though the past year and year to date returns remain in decline. The sector is reacting to the idea that rent and occupancy look stable, while investors compare REIT income streams with term deposits and a 4.6% cash rate.

The single hinge for property heavy portfolios is tomorrow's RBA decision and statement. Any change to the cash rate, or firmer language on inflation, would move funding costs for landlords and could quickly reset what yield investors demand from listed property.

Materials and Metals and Mining: Short term bounce meets sector stress

Materials and Metals and Mining have bounced over the past week after a weaker month, helped by a supportive commodity price index that is up 12.5% on the year. At the same time, global coverage points to the top 50 mining groups losing about 26% of their combined market value since February, which keeps attention on balance sheets and project risk.

For holders of miners tied to iron ore, copper or gold, the key upcoming signal is Australia's September trade data on Thursday. A stronger or softer export line will show how much of that global pressure is flowing through to local producers that feed into the ASX Materials sector.

Financials and Banks: Solid month as housing cools

Financials and Banks have been positive over the past month, with sector returns now ahead year to date even as mortgage growth at major lenders has flattened. Updates from groups like Westpac and National Australia Bank highlight a mix of steady profits and a housing downturn that is pressuring loan growth and keeping a close eye on bad debts.

If you rely on bank dividends, the key catalyst is tomorrow's RBA decision. Any move away from the current 4.6% cash rate, plus comments on arrears and household stress, will shape how boards think about future payout levels and capital buffers.

Consumer Discretionary: Rate sensitive names stay under pressure

Consumer Discretionary has slipped over the past 7 days after a stronger month and remains clearly weaker over 1 year and year to date. Higher borrowing costs together with a 4.3% annual inflation read mean less spare cash for travel, fashion and leisure, which weighs on retailers and other non essential spending plays.

For any holdings tied to household spending, focus on trading updates from listed retailers over the next few weeks. References to smaller basket sizes, weaker store traffic or heavier discounting give early clues about how tighter budgets after the RBA meeting could feed into margins.

Healthcare and Pharmaceuticals & Biotech: Gradual rebuild helped by stock specific wins

Healthcare has edged higher over the past month after a softer year, while Pharmaceuticals & Biotech have been firmer over the past 7 days. Recent news such as Neuren's US FDA Orphan Drug Designation and strong product updates from groups like Orthocell and Noxopharm underline how individual milestones can support this corner of the market even when the broader index is flat.

For investors with Healthcare exposure, the main trigger to watch is the next wave of quarterly and clinical updates. Details on cash usage, trial timing and overseas sales progress often move these stocks far more than macro data like the RBA decision or inflation prints.

Find Stocks Poised To Move

With Real Estate and Financials both tied tightly to tomorrow's RBA rate call, you can stress test that rate story against this list of 6 resilient stocks with low risk scores .

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

Mobilize your Website
View Site in Mobile | Classic
Share by: